For more information and access to our Research reports please contact Luke Kottke or Matthew Moschovas on the Capital Markets desk – 212.953.4917/4949 or lkottke@laidlawltd.com
Coverage List
ADMA Biologics (ADMA) | Eyepoint Pharmaceuticals (EYPT) | OPKO Health, Inc. (OPK) |
Affimed (AFMD) | Fennec Pharmaceuticals (FENC) | Plus Therapeutics (PSTV) |
Aldeyra Therapeutics (ALDX) | Hoth Therapeutics (HOTH) | Sesen Bio (SESN) |
Alimera Sciences (ALIM) | iCAD Inc. (ICAD) | Soleno Therapeutics (SLNO) |
Athenex (ATNX) | Ionis Pharmaceuticals (IONS) | Taiwan Liposome Company (TLC) |
Beyond Air (XAIR) | MEI Pharma (MEIP) | Tisane Life Sciences (TLSA) |
BioSig Technologies (BSGM) | Molecular Templates (MTEM) | Viking Therapeutics (VKTX) |
Evoke Pharma (EVOK) | Onconova Therapeutics (ONTX) | Ziopharm Oncology (ZIOP) |